Acutaas Chemicals Ltd.
Research Acutaas Chemicals Ltd. (ACUTAAS.NS) on Bullrun: market cap INR 262.48B, P/E 68.2, dividend yield 0.1%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerACUTAAS.NS
- ExchangeNSE
- CountryIndia
- SectorBasic Materials
- IndustrySpecialty Chemicals
- CurrencyINR
- Market capINR 262.48B
- P/E68.2
- Dividend yield0.1%
- Financial periodQ2 2026
- RevenueINR 3.30B
- Net incomeINR 742.60M
- Gross margin57.9%
Valuation Snapshot
latest market cap is INR 262.48B; P/E is 68.2; dividend yield is 0.1%.
Peer valuation comparison
Latest P/E is 68.21x versus a Basic Materials sector median of 15.25x (347.2% above).
Latest dividend yield is 0.08% versus a Basic Materials sector median of 2.55% (96.9% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | INR 262.48B | 68.2 | 0.1% | 2.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.5 INR, yield 0.1%.
About Acutaas Chemicals Ltd.
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells;
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is Acutaas Chemicals Ltd.'s market cap?
Acutaas Chemicals Ltd.'s market capitalization is INR 262.48B.
What is Acutaas Chemicals Ltd.'s P/E ratio?
Acutaas Chemicals Ltd.'s price-to-earnings (P/E) ratio is 68.2.
Does Acutaas Chemicals Ltd. pay a dividend?
Acutaas Chemicals Ltd. has a dividend yield of 0.1%.
What does Acutaas Chemicals Ltd. do?
Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals.